View Press Releases
-
Creative Biostructure Announces Comprehensive Exosome Analysis Services
-
Securing the Integrity of Microneedle Structure Design and Optimization: CD Formulation's Performance Testing Approach
-
CD BioGlyco Releases One-Stop Services for Glycoprotein-Based Vaccine Development
-
Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma’s portfolio companies
-
Alfa Chemistry Announces the Launch of Innovative IVD Products for Laboratory Use
-
Optibrium introduces cloud-based version of StarDrop drug discovery platform
Optibrium introduces a cloud-based version of StarDrop, its drug discovery platform.
Oct 22, 2023
-
Creative Enzymes Unveils the Creative SuperCut Series: Redefining Precision in Molecular Biology
-
Creative Enzymes Unveils Advanced Substrate, Inhibitor, and Ligand Screening Services
-
Creative Biolabs Unveils ADC Services, Igniting Excitement in the Biotech Industry
Creative Biolabs, a prominent provider of groundbreaking biotechnology solutions, proudly announced the expansion of its antibody-drug conjugate (ADC) business with the introduction of novel services.
Oct 22, 2023
-
Empowering Research Excellence: Alfa Chemistry's THEIC, D-Pantethine, and Methoxytriethyleneoxypropyltrimethoxysilane at the Forefront
-
Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases
Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Purespring Therapeutics, a biotech innovator company, to accelerate the manufacture of their gene therapies for the treatment of chronic renal diseases that are currently poorly addressed.
Oct 19, 2023
-
CD Formulation's Scientists Share A Holistic Approach on How to Prepare Drug Microcapsules
-
Magritek opens up benchtop NMR to new reaction monitoring applications
-
Cresset Targets International Growth with Innovate UK Scaleup Programme
Drug discovery specialists Cresset have joined Innovate UK’s Scaleup Programme for businesses with high growth potential
Oct 17, 2023
-
New £30m Initiative to Address Global Threat by Accelerating the Pace of Antimicrobial Innovation
Pioneering partnership to drive development of new tests and treatments to tackle deadly antimicrobial resistance, which could otherwise kill 10 million a year by 2050
Oct 18, 2023
-
CD Genomics Revolutionizes TCR-Seq Elevating Immune Repertoire Profiling to New Heights
-
CD Genomics Unveils Cutting-Edge CRISPR Screen Sequencing Technology
-
CD Genomics Introduces Cutting-Edge Degradome Sequencing Service Redefining Transcriptomics Research
-
BOC Sciences at TIDES Europe 2023: Key Chemicals and XDC Platform to Be Exhibited
BOC Sciences will attend "TIDES Europe: Oligonucleotide & Peptide Therapeutics", delivered as a hybrid event from 30 Oct - 1 Nov 2023, in Amsterdam, NL. Its high-yield nucleosides & nucleotides, as well as a newly launched XDC platform, will be exhibited in front of the industry.
Oct 18, 2023
-
Biotium Introduces New Highly-Selective Stains For Both Gram-Positive and Gram-Negative Bacteria
Biotium has announced the launch of its breakthrough BactoView™ Dead Stains and BactoView™ Viability Kits.
Oct 17, 2023